Showing results (2771-2780 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|June 28, 2005
Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsyKristin Cecilie Carlsson, Nils Ove Hoem, Tracy Glauser, et al.Clinical Therapeutics|June 28, 2005
Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid populationAncilla W Fernandes, S Suresh Madhavan, Mayur M AmonkarClinical Therapeutics|August 25, 2005
Anesthesia and analgesia during and after surgery in neonatesCharles B Berde, Tom Jaksic, Anne M Lynn, et al.Clinical Therapeutics|October 4, 2005
Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitationMarc Laruelle, W Gordon Frankle, Rajesh Narendran, et al.Clinical Therapeutics|August 25, 2005
Newborns and drug studies: the NICHD/FDA newborn drug development initiativeGeorge P Giacoia, Donald R MattisonClinical Therapeutics|October 4, 2005
Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetesJohn B Buse, Cindy J Rubin, Robert Frederich, et al.Clinical Therapeutics|October 4, 2005
A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemiaAlexandria Garavaglia Wilson, Scott T Micek, David J RitchieClinical Therapeutics|October 4, 2005
Clinical applications of exhaled nitric oxide for the diagnosis and management of asthma: a consensus reportMyron ZittClinical Therapeutics|October 4, 2005
A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumoniaAndrew F Shorr, Neringa Zadeikis, Jim X Xiang, et al.Pageof 678